Trend in incidence of gastric adenocarcinoma by tumor location from 1969-2004; a study in one referral center in Iran

Diagnostic Pathology

Volumn 1, Issue 1, 2006, Pages

  Abdi Rad, Afshin ^a   Ghaderi sohi, Siavash ^a   Nadimi Barfroosh, Hosein ^a   Emami, Sara ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248200352     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-1-5     Document Type: Article

References (65)

1. Jemel A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M: Cancer statistics, 2003. CA Cancer J Clin 2004, 54:8-29.
2. Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF: Is gastric carcinoma different between Japan and United State? Cancer 2000, 89:2237-46.
3. Mohagheghi MA: Final report of national research for cancer registration in Iran. National Cancer Registration of Iran 2002.
4. Mossavi Jarrahi A, Mohagheghi M, Yazdizadeh B, Kolahi AA, Tahmasebi S, Sharifi K: Analysis of smoking behavior in Iranian population: A cohort & period analysis. Asian Pacific Journal of cancer prevention 2004, 5:25-8.
5. Ekstrom AM, Hansson LE, Signorello LB, Lindgren A, Bergstrom R, Nyren O: Decreasing incidence of both major histologic sub-types of gastric adenocarcinoma-a population-based study in Sweden. Br J Cancer 2000, 83:391-6.
6. Devesa SS, Blot WJ, Fraumeni JF: Changing patterns in the Incidence of esophageal and gastric carcinoma in the United States. Cancer 1998, 83:2049-53.
7. Devesa SS, Fraumeni JF: The Rising incidence of gastric cardia cancer. Journal of the National Cancer Institute 1999, 91:747-9.
8. Antonio li DA, Goldman H: Changes in the location and type of gastric adenocarcinoma. Cancer 1982, 50:775-81.
9. MacDonald WC, Mac Donald JB: Adenocarcinoma of the esophagus and/or gastric cardia. Cancer 1987, 60:1094-98.
10. Rios-Castellanos E, Sitas F, shepherd NA, Jewell DP: Changing pattern of gastric cancer in Oxfordshire. Gut 1992, 33:1312-17.
11. Harrison SL, Goldacre MJ, Seagrott V: Trends in registered incidence of esophageal and stomach cancer in Oxford region, 1974-88. European Journal of cancer prevention 1992, 1:271-4.
12. Moller H: Incidence of cancer of esophagus, cardia and stomach, in Denmark. European Journal of cancer prevention 1992, 1:159-64.
13. Van der Sanden GAC, Coebergh JWW, Vander Heijden LH, Verhagen TMT: Trends in incidence of the gastrointestinal cancer in the southeastern Netherlands, 1975-1989. Tijdschr soc Gezondheidsz 1993, 71:326-32.
14. Hansson LE, Sparen Q, Nyren O: Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. British Journal of surgery 1993, 80:374-7.
15. Armstrong RW, Borman B: Trends in incidence rates of adenocarcinoma of the esophagus and gastric cardia in New Zealand, 1978-1992. International Journal of epidemiology 1996, 25:941-7.
16. Hansens S, Wiig JN, Giercksky KE, Tretli S: Esophageal and gastric carcinoma in Norway 1058-1992: incidence time trend variability according to morphological subtypes and organ subsites. International Journal of cancer 1997, 71:340-4.
17. Macfarlane GJ, Plesko I, Kramurova E, Obsitnikova A, Boyle P: Epidemiological features of gastric and esophageal cancer in Slovakia. British Journal of cancer 1994, 70:177-9.
18. Thomas RJ, Lade S, Gilas GG, Tharsfield V: Incidence trends in esophageal and proximal gastric carcinoma in victoria. Austria New Zeeland Journal of Surgery 1996, 66:271-5.
19. Kampschoer GH, Nakajina T, Van de Velde CJ: Changing patterns in gastric adenocarcinoma. British Journal of surgery 1989, 76:914-6.
20. Blaser MJ, Saito D: Trends in reported adenocarcinomas of the esophagus and gastric cardia in Japan. European Journal of gastroenterology and hepatology 2002, 14:107-13.
21. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991, 265:1287-9.
22. McKinney PA, Sharp L, Macfarlane GJ, Muir CS: Esophageal and gastric cancer in Scotland 1960-1990. Br J Cancer 1995, 71:411-5.
23. Lee Jy, Kim, Hy, Kim KH, Jang HJ, Kin JB, Lee JH, et al.: No changing trends in incidence of gastric cardia cancer in Korea, Journal of Korean medical science 2003, 18:53-7.
24. Goto H, Ohmiya N, Kamiya K, Ando N, Sakata T, Hayakawa T: Did gastric cancer vary over 30 years in Japan? Gastroenterology 2001, 120(Suppl 1):255.
25. Botterweek Anita Am, Schouten LJ, Volorics A, Orant E, Van den Brandt P: Trends in incidence of adenocarcinoma of the esophagus and gastric cardia in ten European countries. International Journal of epidemiology 2000, 29:645-54.
26. Corley DA, Buffler PA: Esophageal and gastric cardia adenocarcinomas: analysis of regional variation using the cancer incidence in five continents database. International Journal of epidemiology 2001, 30:1415-23.
27. Liu Y, Kaneko S, Sobue T: Trends in reported incidences of gastric cancer by tumor location, from 1975 to 1989 in Japan. International Journal of epidemiology 2004, 33:808-15.
28. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma. 13th edition. Tokyo: Kanehara 800. Ltd; 1999.
29. Misumi A, Murakami A, Harada K, Akagi M: Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir 1989, 377:221-9.
30. Owen DA: The stomach. In Sternberg's Diagnostic Surgical Pathology 4th edition. Edited by: Mills SE, Catter D, Greenson JK, Oberman HA, Reuter V, Stoler MH. Lippincot Williams & Wilkins, Philadelphia; 2004:1435-74.
31. Ekström AM, Signorello LB, Hansson LE, Bergstrom R, Lindgren A, Nyren O: Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence, Journal of the National Cancer Institute 1999, 91:786-90.
32. + strains of helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998, 15:588-90.
33. Erkisi M, Colakoglu S, Koksal F, et al.: Relationship of Helicobacter Pylori infection to several malignant and non malignant gastrointestinal diseases. J Exp Clin Cancer Res 1997, 16:289-93.
34. + immuniblot as marker of past infection. Gostroenterotogy 2201, 121:784-91.
35. Hunt RH, Sumanac K, Huang JQ: Review article: Should we kill or should we save Helicobacter Pylori? Aliment Pharmacol Ther 2001, 15(suppl. 1):51-9.
36. Correa P, Shiao YH: Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994, 54(Suppl):S1941-3.
37. Hansen LR, Engstrand L, Nyren O, Lindgren A: Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995, 109:885-8.
38. de Koewin JD: Eradication of Helicobacter Pylori. Is it necessary to eradicate Helicobacter Pylori in gastric reflux? Press Med 2001, 30:1313-20.
39. Kandel G: Helicobacter and disease: still more question than answers. Can J Surg 2000, 43:339-46.
40. Legergren J, Bergstrom R, Adami HO, Nyren O: Association between medication that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Int Med 2000, 133:165-75.
41. Terry P, Lagergren J, Ye W, Nyren O, Wolk A: Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer 2000, 87:750-54.
42. Lagergren J, Bergstrom R, Nyren O: Ann Intern Med 1999, 130:883-90.
43. Spechler SJ: The role of gastric carditis in metaplasia and neoplasia at the gastroesophagial junction. Gostroentero/ogy 1999, 117:218-28.
44. Pera M: Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction. Recent Results Cancer Res 2000, 155:1-14.
45. Limburg P, Qiao Y, Mark S, et al.: Helicobacter Pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst 2001, 93:226-33.
46. Terry P, Lagergren J, Hansen H, Wolk A, Nyren O: Fruit and vegetable consumption in the prevention of esophageal and cardia cancers. Eur J Cancer Prey 2001, 10:365-69.
47. Sasazuki S, Sasaki S, Tsugane S: for the Japan Public Health Center Study Group. Cigarette smoking, alcohol consumption and sub sequent gastric cancer risk by subsite and histologic type. Int J Cancer 2002, 101:560-66.
48. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, et al.; Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997, 89:1277-84.
49. Gray JR. Coldman AJ, MacDonald WC: Cigarette and alcohol use in patients with adenocarcinoma of the gastric cardia or lower esophagus. Cancer 1992, 69:2227-31.
50. Kabat GC, Ng SK, Wynder EL: Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control 1993, 4:123-32.
51. Zhang ZF, Kurtz RC, Sun M, Karpeh MJR, Yu GP, Gargon N, et al.: Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996, 5:761-8.
52. Brown LM, Silverman DT, Pottern LM, Schoenberg JB, Greenberg RS, Swanson GM, et al.: Adenocarcinoma of the esophagus and esophagogastric junction in withe men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control 1994, 5:333-40.
53. Vaughan TL, Davis S, Kristal A, Thomas DB: Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995, 4:85-92.
54. Garidou A, Tzonou A, Lipworth L, Signorello LB, Kalapothaki V, Trichopoulos D: Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population. Int J Cancer 1996, 68:295-9.
55. Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, et al.: Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia, J Natl Cancer Inst 1998, 90:150-5.
56. Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, et al.: Adenocarcinoma of the esophagus: role of obesity and diet, J Natl Cancer Inst 1995, 87:104-9.
57. Corvalan A, Koriyama C, Akiba S, et al.: Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile. Int J Cancer 2001, 94:527-30.
58. Lee KH, Lee JS, Suh C, et al.: Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases. Cancer 1995, 75:2794-801.
59. Shen H, Xu Y, Qlen Y, et al.: polymorphisms of the DNA repair gene XRCCI and risk of gastric cancer in a Chinese population. Int J Cancer 2000, 88:601-06.
60. Kakiuchi H, Itoh F, Kusano M, et al.: familial gastric cancer in in the Japanese population is frequently located at the cardiac region. Tumor Biol 1999, 20:235-41.
61. Liu Y, Yushimura K, Yamaguchi N, Shinmura K, Yokota J, Katai H: Causation of Burrmann type 4 gastric cancer: heritable factors or environmental factors? Gastric cancer 2003, 6:17-23.
62. Yang PC, Davis S: Incidence of cancer of esophagus in the US by histologic type. Cancer 1988, 61:612-17.
63. Correa P, Chen VW: Gastric cancer. Cancer Surv 1994, 19-20:55-76.
64. Yang PC, Davis S: Epidemiological characteristics of adenocarcinoma of the gastric cardia and distal stomach in the United States, 1973-1982. Int J Epidemiol 1988, 17:293-7.
65. Liabeuf A, Faivre J: Time trends in esophageal cancer incidence in Cote d'Or (France), 1976-93. Eur J Cancer Prev 1997, 6:24-30.